157 related articles for article (PubMed ID: 26101617)
1. Tolerance and the effect of high doses of wheat bran extract, containing arabinoxylan-oligosaccharides, and oligofructose on faecal output: a double-blind, randomised, placebo-controlled, cross-over trial.
François IE; Lescroart O; Veraverbeke WS; Windey K; Verbeke K; Broekaert WF
J Nutr Sci; 2014; 3():e49. PubMed ID: 26101617
[TBL] [Abstract][Full Text] [Related]
2. Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial.
François IE; Lescroart O; Veraverbeke WS; Marzorati M; Possemiers S; Evenepoel P; Hamer H; Houben E; Windey K; Welling GW; Delcour JA; Courtin CM; Verbeke K; Broekaert WF
Br J Nutr; 2012 Dec; 108(12):2229-42. PubMed ID: 22370444
[TBL] [Abstract][Full Text] [Related]
3. Effects of wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal parameters in healthy preadolescent children.
François IE; Lescroart O; Veraverbeke WS; Marzorati M; Possemiers S; Hamer H; Windey K; Welling GW; Delcour JA; Courtin CM; Verbeke K; Broekaert WF
J Pediatr Gastroenterol Nutr; 2014 May; 58(5):647-53. PubMed ID: 24368315
[TBL] [Abstract][Full Text] [Related]
4. High dose of prebiotics reduces fecal water cytotoxicity in healthy subjects.
Windey K; François I; Broekaert W; De Preter V; Delcour JA; Louat T; Herman J; Verbeke K
Mol Nutr Food Res; 2014 Nov; 58(11):2206-18. PubMed ID: 25164793
[TBL] [Abstract][Full Text] [Related]
5. Wheat bran extract alters colonic fermentation and microbial composition, but does not affect faecal water toxicity: a randomised controlled trial in healthy subjects.
Windey K; De Preter V; Huys G; Broekaert WF; Delcour JA; Louat T; Herman J; Verbeke K
Br J Nutr; 2015 Jan; 113(2):225-38. PubMed ID: 25498469
[TBL] [Abstract][Full Text] [Related]
6. Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study.
Cloetens L; Broekaert WF; Delaedt Y; Ollevier F; Courtin CM; Delcour JA; Rutgeerts P; Verbeke K
Br J Nutr; 2010 Mar; 103(5):703-13. PubMed ID: 20003568
[TBL] [Abstract][Full Text] [Related]
7. Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit.
Müller M; Hermes GDA; Emanuel E C; Holst JJ; Zoetendal EG; Smidt H; Troost F; Schaap FG; Damink SO; Jocken JWE; Lenaerts K; Masclee AAM; Blaak EE
Gut Microbes; 2020 Nov; 12(1):1704141. PubMed ID: 31983281
[TBL] [Abstract][Full Text] [Related]
8. Consumption of breads containing in situ-produced arabinoxylan oligosaccharides alters gastrointestinal effects in healthy volunteers.
Damen B; Cloetens L; Broekaert WF; François I; Lescroart O; Trogh I; Arnaut F; Welling GW; Wijffels J; Delcour JA; Verbeke K; Courtin CM
J Nutr; 2012 Mar; 142(3):470-7. PubMed ID: 22298569
[TBL] [Abstract][Full Text] [Related]
9. Effects of wheat bran and Olestra on objective measures of stool and subjective reports of GI symptoms.
McRorie J; Kesler J; Bishop L; Filloon T; Allgood G; Sutton M; Hunt T; Laurent A; Rudolph C
Am J Gastroenterol; 2000 May; 95(5):1244-52. PubMed ID: 10811335
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers.
Walton GE; Lu C; Trogh I; Arnaut F; Gibson GR
Nutr J; 2012 Jun; 11():36. PubMed ID: 22657950
[TBL] [Abstract][Full Text] [Related]
11. Consuming foods with added oligofructose improves stool frequency: a randomised trial in healthy young adults.
Dahl WJ; Wright AR; Specht GJ; Christman M; Mathews A; Meyer D; Boileau T; Willis HJ; Langkamp-Henken B
J Nutr Sci; 2014; 3():e7. PubMed ID: 25191615
[TBL] [Abstract][Full Text] [Related]
12. Additional oligofructose/inulin does not increase faecal bifidobacteria in critically ill patients receiving enteral nutrition: a randomised controlled trial.
Majid HA; Cole J; Emery PW; Whelan K
Clin Nutr; 2014 Dec; 33(6):966-72. PubMed ID: 24290345
[TBL] [Abstract][Full Text] [Related]
13. Safety assessment of a wheat bran extract containing arabinoxylan-oligosaccharides: mutagenicity, clastogenicity, and 90-day rat-feeding studies.
François IE; Lescroart O; Veraverbeke WS; Kubaszky R; Hargitai J; Esdaile DJ; Beres E; Soni MG; Cockburn A; Broekaert WF
Int J Toxicol; 2010; 29(5):479-95. PubMed ID: 20884858
[TBL] [Abstract][Full Text] [Related]
14. Effects of wheat bran extract rich in arabinoxylan oligosaccharides and resistant starch on overnight glucose tolerance and markers of gut fermentation in healthy young adults.
Boll EV; Ekström LM; Courtin CM; Delcour JA; Nilsson AC; Björck IM; Östman EM
Eur J Nutr; 2016 Jun; 55(4):1661-70. PubMed ID: 26169871
[TBL] [Abstract][Full Text] [Related]
15. The effect of age, sex and level of intake of dietary fibre from wheat on large-bowel function in thirty healthy subjects.
Stephen AM; Wiggins HS; Englyst HN; Cole TJ; Wayman BJ; Cummings JH
Br J Nutr; 1986 Sep; 56(2):349-61. PubMed ID: 2823871
[TBL] [Abstract][Full Text] [Related]
16. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake.
Verhoef SP; Meyer D; Westerterp KR
Br J Nutr; 2011 Dec; 106(11):1757-62. PubMed ID: 21679485
[TBL] [Abstract][Full Text] [Related]
17. An Investigation of the Acute Effects of Oligofructose-Enriched Inulin on Subjective Wellbeing, Mood and Cognitive Performance.
Smith AP; Sutherland D; Hewlett P
Nutrients; 2015 Oct; 7(11):8887-96. PubMed ID: 26516908
[TBL] [Abstract][Full Text] [Related]
18. Oligofructose Provides Laxation for Irregularity Associated with Low Fiber Intake.
Buddington RK; Kapadia C; Neumer F; Theis S
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29258261
[TBL] [Abstract][Full Text] [Related]
19. Arabinoxylan oligosaccharides and polyunsaturated fatty acid effects on gut microbiota and metabolic markers in overweight individuals with signs of metabolic syndrome: A randomized cross-over trial.
Kjølbæk L; Benítez-Páez A; Gómez Del Pulgar EM; Brahe LK; Liebisch G; Matysik S; Rampelli S; Vermeiren J; Brigidi P; Larsen LH; Astrup A; Sanz Y
Clin Nutr; 2020 Jan; 39(1):67-79. PubMed ID: 30827722
[TBL] [Abstract][Full Text] [Related]
20. Increasing butyrate concentration in the distal colon by accelerating intestinal transit.
Lewis SJ; Heaton KW
Gut; 1997 Aug; 41(2):245-51. PubMed ID: 9301506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
